Jenny Rooke, Ph.D.

Managing DirectorGenoa Ventures

For over a decade, Genoa Ventures’ Founder and Managing Director Jenny Rooke, Ph.D. has been deploying capital at the frontiers of life sciences innovation, with a penchant for technology-fueled solutions and category-defying opportunities. Dr. Rooke got her start in venture at Fidelity Biosciences, a Cambridge-based healthcare VC, during its Fund I formation. She then brought her unique toolkit of genetics domain expertise, strategic business acumen and venture investing to the Gates Foundation, where she deployed and managed over $250M in funding in genetic engineering, diagnostics and synthetic biology. She also played a key role in establishing the foundation’s investing function. In 2014, Dr. Rooke began independently investing under the brand 5 Prime Ventures, financing her investments using what has become the largest life sciences syndicate on AngelList, and one of the highest-performing AngelList syndicates of any sector. She founded Genoa Ventures in 2018, building on the 5 Prime Ventures track record, in order to scale a proven, differentiated investing strategy, to ensure continued access to the very best deals, and to maximize portfolio returns.

Sessions
Oct 23 3:00 PM Investing trends in the innovation economy

A discussion with Skip Kelly, Silicon Valley Bank